Adaptive Biotechnologies
ADPT
#5648
Rank
โ‚น81.13 B
Marketcap
โ‚น549.76
Share price
0.94%
Change (1 day)
30.89%
Change (1 year)

Revenue for Adaptive Biotechnologies (ADPT)

Revenue in 2024 (TTM): โ‚น14.79 Billion

According to Adaptive Biotechnologies 's latest financial reports the company's current revenue (TTM ) is โ‚น15.11 Billion. In 2023 the company made a revenue of โ‚น14.17 Billion a decrease over the revenue in the year 2022 that were of โ‚น15.33 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adaptive Biotechnologies from 2018 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น14.79 B4.34%
2023 โ‚น14.17 B-7.56%
2022 โ‚น15.33 B33.48%
2021 โ‚น11.48 B59.67%
2020 โ‚น7.19 B18.6%
2019 โ‚น6.06 B55.87%
2018 โ‚น3.89 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น5.934 T 39,171.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น108.73 B 619.62%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.069 T 6,980.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น593.95 B 3,830.77%๐Ÿ‡บ๐Ÿ‡ธ USA